• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Veno-occlusive disease of the liver after chemotherapy for rhabdomyosarcoma: case report with a review of the literature.

作者信息

Kanwar V S, Albuquerque M L, Ribeiro R C, Kauffman W M, Furman W L

机构信息

Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN 38101-0318.

出版信息

Med Pediatr Oncol. 1995 May;24(5):334-40. doi: 10.1002/mpo.2950240513.

DOI:10.1002/mpo.2950240513
PMID:7700188
Abstract

We describe the case of a 3-year-old girl who developed veno-occlusive disease of the liver while receiving chemotherapy for parameningeal rhabdomyosarcoma. After suffering lethargy and oral mucosal bleeding for one day, the patient exhibited a sudden weight gain and refractoriness to platelet transfusions. Symptoms rapidly worsened with elevation of liver enzymes, bleeding diatheses, and respiratory failure. An ultrasound scan of the liver demonstrated reversed flow in the portal vein. Maximal supportive care, including tracheal intubation and mechanical ventilation, was required. The patient gradually recovered with no respiratory and minimal neurological sequelae. Veno-occlusive disease of the liver should be considered in children receiving chemotherapy who develop weight gain, a sudden drop in platelet count and derangement of liver enzymes. Aggressive supportive measures should be instituted if necessary, as patients surviving the acute phase can expect to make a full recovery.

摘要

相似文献

1
Veno-occlusive disease of the liver after chemotherapy for rhabdomyosarcoma: case report with a review of the literature.
Med Pediatr Oncol. 1995 May;24(5):334-40. doi: 10.1002/mpo.2950240513.
2
Veno-occlusive disease in a child with rhabdomyosarcoma after conventional chemotherapy: report of a case and review of the literature.常规化疗后横纹肌肉瘤患儿发生肝静脉闭塞病:一例报告并文献复习
Pediatr Hematol Oncol. 2007 Dec;24(8):615-21. doi: 10.1080/08880010701640390.
3
Veno-occlusive disease of the liver after combined adjuvant chemotherapy for a 1-year-old boy with rhabdomyosarcoma: potential usefulness of the gabexate mesylate (FOY).一名1岁横纹肌肉瘤男孩接受联合辅助化疗后发生肝静脉闭塞性疾病:甲磺酸加贝酯(FOY)的潜在作用
J Pediatr Gastroenterol Nutr. 1992 Apr;14(3):314-8. doi: 10.1097/00005176-199204000-00013.
4
Veno-occlusive disease in pediatric patients receiving actinomycin D and vincristine only for the treatment of rhabdomyosarcoma.仅接受放线菌素D和长春新碱治疗横纹肌肉瘤的儿科患者中的静脉闭塞性疾病。
J Pediatr Hematol Oncol. 2004 Dec;26(12):843-6.
5
Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Childrens Cancer Group, the Pediatric Oncology Group, and the Pediatric Intergroup Statistical Center.长春新碱、放线菌素D和环磷酰胺化疗治疗横纹肌肉瘤后发生的肝静脉闭塞性疾病。横纹肌肉瘤研究组间报告。儿童癌症组、儿科肿瘤学组和儿科组间统计中心。
Cancer. 1997 Jun 15;79(12):2435-9. doi: 10.1002/(sici)1097-0142(19970615)79:12<2435::aid-cncr21>3.0.co;2-r.
6
Severe Hepatic Sinusoidal Obstruction Syndrome in a Child Receiving Vincristine, Actinomycin-D, and Cyclophosphamide for Rhabdomyosarcoma: Successful Treatment with Defibrotide.儿童横纹肌肉瘤接受长春新碱、放线菌素-D 和环磷酰胺治疗后发生严重肝窦阻塞综合征:使用去纤维蛋白治疗取得成功。
Cancer Res Treat. 2016 Oct;48(4):1443-1447. doi: 10.4143/crt.2016.096. Epub 2016 Mar 30.
7
Veno-occlusive disease-like hepatotoxicity in two children receiving chemotherapy for Wilms' tumor and clear cell sarcoma of kidney.两名接受化疗治疗肾母细胞瘤和肾透明细胞肉瘤的儿童出现类似肝静脉闭塞病的肝毒性。
Pediatr Hematol Oncol. 1998 Jan-Feb;15(1):85-9. doi: 10.3109/08880019809009513.
8
Fatal hepatic veno-occlusive disease with fibrinolysis as the cause of death during preoperative chemotherapy for nephroblastoma.
Med Pediatr Oncol. 1998 Sep;31(3):175-6. doi: 10.1002/(sici)1096-911x(199809)31:3<175::aid-mpo10>3.0.co;2-1.
9
[Veno-occlusive disease of the liver as a treatment complication in children with Wilm's tumor].
Padiatr Padol. 1992;27(2):47-50.
10
Fatal hepatic veno-occlusive disease in an adult patient with Wilms' tumour.一名患有肾母细胞瘤的成年患者发生致命性肝静脉闭塞病。
Clin Oncol (R Coll Radiol). 2003 Sep;15(6):366. doi: 10.1016/s0936-6555(03)00160-2.

引用本文的文献

1
Drug-induced sinusoidal obstruction syndrome: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System (FEARS).药物性窦性阻塞综合征:一项基于美国食品药品监督管理局不良事件报告系统(FEARS)的真实世界药物警戒研究。
BMC Pharmacol Toxicol. 2025 Jul 18;26(1):135. doi: 10.1186/s40360-025-00965-5.
2
Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low-risk clinical trials: A report from the Children's Oncology Group.低危临床试验治疗的胆道横纹肌肉瘤患者结局不佳:儿童肿瘤协作组的报告。
Pediatr Blood Cancer. 2021 Apr;68(4):e28914. doi: 10.1002/pbc.28914. Epub 2021 Jan 26.
3
Adjuvant recombinant thrombomodulin therapy for hepatopathy induced by vincristine, actinomycin D, and cyclophosphamide in pediatric rhabdomyosarcoma: A case report.
辅助重组血栓调节蛋白治疗小儿横纹肌肉瘤中长春新碱、放线菌素D和环磷酰胺所致肝病:一例报告
Mol Clin Oncol. 2019 Aug;11(2):208-212. doi: 10.3892/mco.2019.1864. Epub 2019 May 22.
4
Characterisation of the clinical pharmacokinetics of actinomycin D and the influence of ABCB1 pharmacogenetic variation on actinomycin D disposition in children with cancer.放线菌素D的临床药代动力学特征以及ABCB1药物遗传学变异对癌症患儿放线菌素D处置的影响。
Clin Pharmacokinet. 2014 Aug;53(8):741-51. doi: 10.1007/s40262-014-0153-2.
5
Hepatic sinusoidal obstruction syndrome during chemotherapy for childhood medulloblastoma: report of a case and review of the literature.儿童髓母细胞瘤化疗期间的肝窦阻塞综合征:1例报告及文献复习
J Pediatr Hematol Oncol. 2014 Jan;36(1):76-80. doi: 10.1097/MPH.0b013e3182a8f352.
6
Hepatic Sinusoidal Obstruction Syndrome in a child after chemotherapy for medulloblastoma.儿童化疗后发生肝窦阻塞综合征(Hepatic Sinusoidal Obstruction Syndrome)。
J Neurooncol. 2010 Mar;97(1):137-41. doi: 10.1007/s11060-009-9996-z. Epub 2009 Aug 23.